Pipeline Watch: Phase III Starts With Gilteritinib, Lumateperone, Pro 140

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.